<DOC>
	<DOCNO>NCT02872740</DOCNO>
	<brief_summary>Title : Embolization Gastric Arterial Supply Weight Loss Sample size : 10 patient Study Population : Morbidly obese patient see bariatric surgery program Toronto Western Hospital either interest eligible surgery . Study Design : Single center , randomize , prospective , non-blinded pilot study . Study Duration : 12 month ( November 2015 - December 2015 ) . Agent : 150-250 micron polyvinyl alcohol particle Primary objective : To evaluate safety embolization leave gastric gastroepiploic artery . To determine either result significant weight loss decrease waist circumference among obese patient . Primary objective measure : The number adverse event 1 year period record . The weight change baseline record .</brief_summary>
	<brief_title>Gastric Arterial Embolization Weight Loss</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Meet standard eligibility criterion bariatric surgery . BMI &gt; = 40 BMI &gt; =35 one follow comorbid condition : hypertension , type 2 diabetes , obstructive sleep apnea , coronary artery disease Basic Unable provide inform consent ( legally authorize representative acceptable ) Unable unwilling come follow appointment Age &lt; 18 &gt; 80 Weight &gt; 400 lbs 180kg due weight limit angiographic table Moderate severe allergy iodinate contrast medium amenable premedication define ACR contrast guideline Pregnant , breastfeed actively try become pregnant next year Inability lie flat duration procedure Limited life expectancy &lt; 1 year Patient enrol another interventional study , permit enter study 30 day reach prior study primary endpoint Arterial anatomy feasible intervention base investigator assessment Gastrointestinal Preexisting chronic abdominal pain History inflammatory bowel disease History gastroparesis Prior history gastric surgery , embolization radiation Prior current history peptic ulcer disease Significant risk factor peptic ulcer disease include daily NSAID use , active smoking active H. Pylori infection Abnormal upper endoscopy Hepatic Cirrhosis Portal venous hypertension Hepatic Bilirubin &gt; 2.0 mg/dL Albumin &lt; 2.5 g/L Cardiovascular Known aortic pathology aneurysm dissection Peripheral arterial disease Renal Renal insufficiency evidence estimate GFR &lt; 60ml/min.1.73m2 Hematologic/Immunologic/Oncologic/Infectious Acute chronic infection Active cancer prior history cancer &lt; 10 year ago Autoimmune disease require immunosuppression Neutrophils &lt; 1.5 x 10^9/L Platelets &lt; 50 x 10^9/L INR &gt; 1.7 Psychiatric Major diagnose psychiatric comorbidities major depressive disorder , schizophrenia , bipolar disorder deem likely interfere follow History eat disorder anorexia bulimia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>